StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
205
This month
5
This year
16
Publishing Date
2022 - 11 - 16
3
2022 - 11 - 01
2
2022 - 07 - 18
2
2022 - 06 - 16
2
2022 - 06 - 10
2
2022 - 05 - 26
2
2022 - 04 - 30
2
2022 - 04 - 29
2
2022 - 03 - 23
2
2022 - 03 - 15
2
2022 - 03 - 11
3
2022 - 03 - 09
2
2022 - 02 - 17
2
2021 - 10 - 11
1
2021 - 10 - 06
1
2021 - 09 - 29
1
2021 - 09 - 17
1
2021 - 09 - 11
1
2021 - 09 - 09
1
2021 - 09 - 07
1
2021 - 08 - 31
2
2021 - 08 - 25
1
2021 - 08 - 10
1
2021 - 08 - 04
1
2021 - 07 - 29
1
2021 - 07 - 28
1
2021 - 07 - 22
2
2021 - 07 - 19
1
2021 - 07 - 02
1
2021 - 06 - 24
1
2021 - 06 - 18
1
2021 - 06 - 16
1
2021 - 06 - 14
1
2021 - 06 - 08
1
2021 - 06 - 04
1
2021 - 05 - 28
2
2021 - 05 - 26
1
2021 - 05 - 20
1
2021 - 05 - 13
1
2021 - 05 - 12
1
2021 - 05 - 06
1
2021 - 05 - 03
1
2021 - 04 - 30
1
2021 - 04 - 29
2
2021 - 04 - 26
1
2021 - 04 - 22
1
2021 - 04 - 16
1
2021 - 04 - 14
1
2021 - 04 - 13
1
2021 - 04 - 07
1
2021 - 03 - 31
1
2021 - 03 - 24
1
2021 - 03 - 11
1
2021 - 03 - 10
1
2021 - 02 - 23
1
2021 - 02 - 18
1
2021 - 02 - 03
1
2021 - 01 - 14
1
2020 - 12 - 18
1
2020 - 12 - 09
1
Sector
Commercial services
18
Communications
1
Consumer non-durables
2
Consumer services
5
Distribution services
6
Electronic technology
4
Energy minerals
1
Finance
18
Health services
205
Health technology
43
Industrial services
7
Manufacturing
1
Producer manufacturing
2
Retail trade
11
Technology services
12
Transportation
1
Tags
Alliances
2
Als
2
Asco
4
Biotech-bay
2
Bladder
3
Breast
6
Breast cancer
3
Cancer
38
China
2
Clinical-trials-phase-iii
2
Collaboration
3
Colorectal cancer
6
Commercialization
3
Conference
17
Covid-19
2
Dating
3
Deadline
8
Diagnostic
6
Disease
6
Earnings
6
Events
14
Expected
2
Fda
3
Foundationone
2
Gastrointestinal
2
Genetic
11
Global
4
Granted
2
Growth
16
Health
9
Heart
4
Immunotherapy
3
Implant
2
In vitro
2
Kidney
12
Liberty
4
Lone-star-bio
37
Lung
3
Management
2
Market
13
Meeting
3
Melanoma
2
N/a
109
Offering
5
One
2
Ovarian cancer
2
People
5
Positive
3
Publication
10
Report
13
Research
23
Results
10
Star
4
Study
10
Symposium
5
Technology
3
Test
35
Therapy
3
Treatment
3
Trial
16
Entities
Abbott laboratories
5
Adaptive biotechnologies corporation
1
Agilent technologies, inc.
6
Agilysys, inc.
1
Amazon.com, inc.
11
Ameresco, inc.
1
Atara biotherapeutics, inc.
1
Autodesk, inc.
2
Avalara, inc.
1
Becton, dickinson and company
1
Bill.com holdings, inc.
1
Bio-rad laboratories, inc.
4
Bio-techne corp
1
Biocept, inc.
3
Biolife solutions, inc.
1
Caredx, inc.
8
Casella waste systems, inc.
6
Centogene n.v.
5
Chegg, inc.
7
Crane co.
2
Danaher corporation
1
Davita inc.
1
Dentsply sirona inc.
2
Durect corporation
1
Dynatrace, inc.
1
Eargo, inc.
1
Emcor group, inc.
1
Exact sciences corporation
4
Facebook, inc.
6
Fleetcor technologies, inc.
2
Fortinet, inc.
1
Fulgent genetics, inc.
3
Grid dynamics holdings, inc.
1
Guardant health, inc.
1
Hologic, inc.
1
Illumina, inc.
17
Invitae corporation
8
Laboratory corporation of america holdings
15
Match group, inc.
2
Montrose environmental group, inc.
4
Morgan stanley
9
Myriad genetics, inc.
6
Natera, inc.
205
Nevro corp.
4
Ocugen, inc.
2
Opko health, inc.
2
Paypal holdings, inc.
2
Perkinelmer, inc.
6
Progyny, inc.
12
Qiagen n.v.
3
Quest diagnostics incorporated
7
Sanofi
2
Signature bank
8
Siteone landscape supply, inc.
6
Sps commerce, inc.
6
Thermo fisher scientific inc
9
Transcat, inc.
3
Vertex, inc.
2
Workday, inc.
9
Yum! brands, inc.
4
Symbols
AAPL
1197
ABB
1426
ABBV
1024
ABLZF
1165
ABT
1786
ACN
600
AMGN
742
ARVL
4293
AZN
664
BDX
796
BMY
662
BNPQF
1764
BNPQY
1764
CSCO
897
DHR
785
ERIC
1612
F
641
FNCTF
7186
FRBA
598
GE
915
GLAXF
657
GOOG
1279
GOOGL
1278
GSK
883
HON
1783
HUBS
1400
IBM
655
INTC
955
IT
594
JNJ
4575
LLY
1708
LTUM
970
LYV
717
MDT
1285
MMM
938
MS
4283
MSFT
1200
MT
589
NOC
589
NOK
900
NOKBF
974
NVO
631
NVS
1241
NVSEF
1031
ORCL
1158
PCRFF
650
PCRFY
650
PFE
692
PHG
962
PPRUF
1128
PPRUY
1129
SAP
1476
SAPGF
1230
SNOW
794
SNY
4534
SNYNF
3592
TEVJF
630
TMO
1622
VZ
1213
XYF
676
Exchanges
Nasdaq
205
Nyse
45
Crawled Date
2022 - 11 - 16
4
2022 - 11 - 01
2
2022 - 07 - 18
2
2022 - 06 - 10
2
2022 - 05 - 26
2
2022 - 05 - 19
2
2022 - 05 - 01
2
2022 - 04 - 29
2
2022 - 03 - 23
2
2022 - 03 - 15
2
2022 - 03 - 11
3
2022 - 02 - 17
2
2021 - 10 - 14
1
2021 - 10 - 11
1
2021 - 10 - 06
1
2021 - 09 - 29
1
2021 - 09 - 17
1
2021 - 09 - 11
1
2021 - 09 - 09
1
2021 - 09 - 07
1
2021 - 08 - 31
2
2021 - 08 - 25
1
2021 - 08 - 10
1
2021 - 08 - 04
1
2021 - 07 - 29
1
2021 - 07 - 28
1
2021 - 07 - 22
2
2021 - 07 - 19
1
2021 - 07 - 02
1
2021 - 06 - 24
1
2021 - 06 - 18
1
2021 - 06 - 16
1
2021 - 06 - 14
1
2021 - 06 - 08
1
2021 - 06 - 04
1
2021 - 05 - 28
2
2021 - 05 - 26
1
2021 - 05 - 20
1
2021 - 05 - 13
1
2021 - 05 - 12
1
2021 - 05 - 06
1
2021 - 05 - 03
1
2021 - 04 - 30
2
2021 - 04 - 29
1
2021 - 04 - 26
1
2021 - 04 - 22
1
2021 - 04 - 16
1
2021 - 04 - 14
1
2021 - 04 - 13
1
2021 - 04 - 07
1
2021 - 03 - 31
1
2021 - 03 - 24
1
2021 - 03 - 11
1
2021 - 03 - 10
1
2021 - 02 - 23
1
2021 - 02 - 19
1
2021 - 02 - 03
1
2021 - 01 - 14
1
2020 - 12 - 18
1
2020 - 12 - 09
1
Crawled Time
00:00
7
00:20
4
01:00
4
03:00
1
04:00
1
04:20
1
05:00
5
06:00
1
07:00
1
08:00
4
09:00
3
10:00
3
11:00
1
12:00
18
12:15
1
12:20
3
12:30
4
13:00
17
13:02
1
13:15
7
13:20
3
13:30
4
14:00
24
14:15
1
14:20
3
14:30
5
15:00
15
15:15
1
15:20
5
15:30
4
16:00
10
16:20
3
17:00
8
17:02
1
18:00
4
19:00
4
20:00
7
20:20
1
21:00
6
22:00
6
23:00
3
Source
www.biospace.com
96
www.globenewswire.com
2
www.natera.com
4
www.prnewswire.com
103
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
NTRA
save search
Liberty All-Star® Growth Fund, Inc. March 2024 Monthly Update
Published:
2024-04-12
(Crawled : 00:20)
- prnewswire.com
AMZN
|
$179.22
-1.14%
-1.15%
30M
|
Retail Trade
|
Email alert
Add to watchlist
TRNS
|
$105.88
1.12%
1.11%
39K
|
Electronic Technology
|
Email alert
Add to watchlist
PGNY
|
$31.88
-2.66%
-2.73%
1.3M
|
Commercial Services
|
Email alert
Add to watchlist
VERX
|
$29.05
-0.55%
-0.55%
280K
|
Technology Services
|
Email alert
Add to watchlist
SPSC
|
$163.3
0.99%
0.98%
220K
|
Technology Services
|
Email alert
Add to watchlist
NTRA
S
|
$87.19
-3.48%
-3.6%
1.1M
|
Health Services
|
Email alert
Add to watchlist
CWST
|
$92.45
0.0%
230K
|
Industrial Services
|
Email alert
Add to watchlist
EME
|
$336.06
-0.93%
2.12%
380K
|
Industrial Services
|
Email alert
Add to watchlist
SITE
|
$158.26
-1.51%
0.0%
230K
|
Distribution Services
|
Email alert
Add to watchlist
CR
|
News
|
$129.39
-0.57%
0.0%
160K
|
Producer Manufacturing
|
Email alert
Add to watchlist
star
update
liberty
growth
Natera Announces Publication of Largest Prospective dd-cfDNA Study in Kidney Transplantation
Published:
2024-04-11
(Crawled : 00:00)
- biospace.com/
NTRA
S
|
$87.19
-3.48%
-3.6%
1.1M
|
Health Services
|
-6.39%
|
O:
-0.36%
H:
0.0%
C:
0.0%
kidney
publication
study
Natera Announces New Data From Two Studies Extending the Clinical Validation of Its Prospera™ Heart dd-cfDNA Test for Heart Transplant Recipients
Published:
2024-04-08
(Crawled : 13:30)
- biospace.com/
NTRA
S
|
$87.19
-3.48%
-3.6%
1.1M
|
Health Services
|
-6.64%
|
O:
0.92%
H:
0.26%
C:
-2.26%
test
for
heart
Natera Announces Positive Surveillance Analysis from the Randomized Phase III IMvigor011 Trial in Muscle-Invasive Bladder Cancer
Published:
2024-04-05
(Crawled : 12:30)
- biospace.com/
NTRA
S
|
$87.19
-3.48%
-3.6%
1.1M
|
Health Services
|
-2.51%
|
O:
2.12%
H:
4.35%
C:
2.25%
bladder
positive
cancer
trial
Natera and Alliance for Clinical Trials in Oncology Announce Activation of Alliance A032103 (MODERN): A Randomized, Phase II/III Adjuvant Trial in Urothelial Cancer
Published:
2024-04-01
(Crawled : 17:00)
- biospace.com/
NTRA
S
|
$87.19
-3.48%
-3.6%
1.1M
|
Health Services
|
-1.24%
|
O:
-0.6%
H:
2.8%
C:
2.25%
cancer
trials
trial
Natera Announces Phase III Randomized CIRCULATE Trial in France, Evaluating Signatera™ in Stage II Colorectal Cancer
Published:
2024-03-18
(Crawled : 12:30)
- biospace.com/
NTRA
S
|
$87.19
-3.48%
-3.6%
1.1M
|
Health Services
|
0.9%
|
O:
0.19%
H:
1.46%
C:
0.48%
cancer
trial
Natera to Present New Data at the 2024 SGO Annual Meeting on Women’s Cancer, Following Recent Medicare Coverage Decisions in Ovarian and Breast Cancers
Published:
2024-03-12
(Crawled : 17:00)
- biospace.com/
NTRA
S
|
$87.19
-3.48%
-3.6%
1.1M
|
Health Services
|
1.18%
|
O:
0.07%
H:
1.68%
C:
1.65%
breast
meeting
Natera to Participate in March Investor Conferences
Published:
2024-02-29
(Crawled : 16:00)
- biospace.com/
NTRA
S
|
$87.19
-3.48%
-3.6%
1.1M
|
Health Services
|
18.0%
|
O:
11.99%
H:
5.68%
C:
0.89%
Natera Announces Fourth Quarter and Fiscal 2023 Earnings Conference Call
Published:
2024-02-20
(Crawled : 14:00)
- biospace.com/
NTRA
S
|
$87.19
-3.48%
-3.6%
1.1M
|
Health Services
|
29.02%
|
O:
-1.86%
H:
2.81%
C:
2.47%
conference
Liberty All-Star® Growth Fund, Inc. January 2024 Monthly Update
Published:
2024-02-13
(Crawled : 23:00)
- prnewswire.com
SITE
|
$158.26
-1.51%
0.0%
230K
|
Distribution Services
|
4.41%
|
O:
5.13%
H:
4.44%
C:
3.2%
DT
4
|
$46.26
4.12%
0.0%
5.5M
|
Technology Services
|
-14.48%
|
O:
0.85%
H:
1.33%
C:
0.5%
CR
|
News
|
$129.39
-0.57%
0.0%
160K
|
Producer Manufacturing
|
6.65%
|
O:
1.1%
H:
1.6%
C:
0.56%
WDAY
S
|
$255.64
-0.54%
-0.54%
1.3M
|
Technology Services
|
-13.39%
|
O:
0.9%
H:
1.46%
C:
0.95%
VERX
|
$29.05
-0.55%
-0.55%
280K
|
Technology Services
|
15.77%
|
O:
0.12%
H:
3.29%
C:
3.17%
TRNS
|
$105.88
1.12%
1.11%
39K
|
Electronic Technology
|
-2.02%
|
O:
0.84%
H:
0.97%
C:
-0.25%
SPSC
|
$163.3
0.99%
0.98%
220K
|
Technology Services
|
-16.27%
|
O:
1.59%
H:
0.96%
C:
-0.02%
RPD
|
$44.16
0.82%
0.82%
550K
|
Technology Services
|
-25.45%
|
O:
1.87%
H:
1.69%
C:
1.25%
PGNY
|
$31.88
-2.66%
-2.73%
1.3M
|
Commercial Services
|
-18.45%
|
O:
1.62%
H:
0.38%
C:
-0.34%
PLMR
|
$77.78
1.14%
1.13%
180K
|
Finance
|
29.4%
|
O:
0.03%
H:
6.33%
C:
4.63%
NTRA
S
|
$87.19
-3.48%
-3.6%
1.1M
|
Health Services
|
32.06%
|
O:
1.08%
H:
1.37%
C:
0.77%
CWST
|
$92.45
0.0%
230K
|
Industrial Services
|
7.48%
|
O:
0.99%
H:
3.81%
C:
3.77%
AMZN
|
$179.22
-1.14%
-1.15%
30M
|
Retail Trade
|
8.7%
|
O:
0.34%
H:
1.18%
C:
1.05%
AGYS
4
|
$81.7
-0.83%
-0.83%
200K
|
Technology Services
|
-7.12%
|
O:
1.27%
H:
1.74%
C:
0.75%
star
update
liberty
growth
New Study Validates Signatera™ in Endometrial Cancer
Published:
2024-02-05
(Crawled : 13:30)
- biospace.com/
NTRA
S
|
$87.19
-3.48%
-3.6%
1.1M
|
Health Services
|
33.37%
|
O:
-0.89%
H:
2.74%
C:
2.52%
cancer
study
Carrier Screening Market Worth $5.4 Billion | MarketsandMarkets™
Published:
2024-01-31
(Crawled : 15:30)
- prnewswire.com
TMO
|
News
|
$541.52
-1.05%
0.61%
2.1M
|
Health Technology
|
-6.02%
|
O:
-0.67%
H:
0.48%
C:
-4.32%
DGX
|
$125.91
-0.84%
-0.7%
870K
|
Health Services
|
-1.09%
|
O:
0.46%
H:
0.41%
C:
-0.76%
LH
M
|
$199.45
-0.26%
0.27%
770K
|
Health Services
|
-11.65%
|
O:
0.53%
H:
0.0%
C:
-2.31%
NVTA
|
$0.019
0.0%
22M
|
Health Services
|
-95.32%
|
O:
-0.2%
H:
2.4%
C:
-3.7%
OPK
|
$1.235
-1.2%
-1.21%
4.1M
|
Health Technology
|
21.78%
|
O:
0.0%
H:
4.95%
C:
0.99%
NTRA
S
|
$87.19
-3.48%
-3.6%
1.1M
|
Health Services
|
36.86%
|
O:
-0.76%
H:
2.2%
C:
0.67%
ILMN
|
$116.64
-1.4%
-1.41%
1.8M
|
Health Technology
|
-19.64%
|
O:
-0.49%
H:
1.17%
C:
-2.37%
CNTG
|
$0.461
-3.96%
-4.12%
23K
|
Commercial Services
|
-58.61%
|
O:
-0.86%
H:
0.0%
C:
-0.43%
market
New Publication Demonstrates Signatera’s Ability to Risk Stratify and Detect Recurrence Early in Resected Stage I-II Lung Cancer
Published:
2024-01-30
(Crawled : 13:30)
- biospace.com/
NTRA
S
|
$87.19
-3.48%
-3.6%
1.1M
|
Health Services
|
36.02%
|
O:
-1.07%
H:
1.73%
C:
0.46%
lung
cancer
publication
risk
Nature Medicine Publishes Two Studies Highlighting Signatera’s Clinical Utility in Patients with Gastrointestinal Malignancies
Published:
2024-01-25
(Crawled : 13:00)
- biospace.com/
NTRA
S
|
$87.19
-3.48%
-3.6%
1.1M
|
Health Services
|
37.68%
|
O:
0.59%
H:
0.64%
C:
-2.09%
gastrointestinal
Invitae Completes Sale of Reproductive Health Assets to Natera
Published:
2024-01-22
(Crawled : 15:30)
- biospace.com/
NVTA
|
$0.019
0.0%
22M
|
Health Services
|
-95.78%
|
O:
-2.76%
H:
0.0%
C:
0.0%
NTRA
S
|
$87.19
-3.48%
-3.6%
1.1M
|
Health Services
|
35.57%
|
O:
2.3%
H:
1.12%
C:
-2.17%
health
Natera Announces Preliminary Fourth Quarter and Full Year 2023 Revenues
Published:
2024-01-09
(Crawled : 14:00)
- biospace.com/
NTRA
S
|
$87.19
-3.48%
-3.6%
1.1M
|
Health Services
|
39.29%
|
O:
-0.31%
H:
5.34%
C:
2.24%
year
Natera Announces New Study Highlighting the Benefits of Signatera’s Unique Method of Quantifying ctDNA
Published:
2023-12-21
(Crawled : 15:00)
- biospace.com/
NTRA
S
|
$87.19
-3.48%
-3.6%
1.1M
|
Health Services
|
57.7%
|
O:
1.62%
H:
5.36%
C:
3.57%
unique
study
benefits
Natera Presents New Signatera™ MRD Data Across Breast Cancer Treatment Settings at SABCS 2023
Published:
2023-12-06
(Crawled : 14:30)
- biospace.com/
NTRA
S
|
$87.19
-3.48%
-3.6%
1.1M
|
Health Services
|
54.99%
|
O:
1.08%
H:
0.45%
C:
-1.71%
breast
cancer
treatment
sabcs
Natera Announces Real-World Data Collaboration with Merck
Published:
2023-11-14
(Crawled : 14:30)
- biospace.com/
NTRA
S
|
$87.19
-3.48%
-3.6%
1.1M
|
Health Services
|
86.09%
|
O:
2.95%
H:
4.4%
C:
4.3%
merck
collaboration
Natera Announces Randomized, Phase III TREAT ctDNA Trial in Early-Stage Breast Cancer
Published:
2023-11-08
(Crawled : 21:00)
- biospace.com/
NTRA
S
|
$87.19
-3.48%
-3.6%
1.1M
|
Health Services
|
106.99%
|
O:
-0.09%
H:
0.0%
C:
-5.18%
breast
cancer
treat
trial
← Previous
1
2
3
4
5
6
7
8
9
10
11
Next →
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
News
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
News
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
News
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.